Amplification of JNK signaling is necessary to complete the murine gammaherpesvirus 68 lytic replication cycle

Journal of Virology

Volumn 86, Issue 24, 2012, Pages 13253-13262

  Stahl, James A ^a   Paden, Clinton R ^c   Chavan, Shweta S ^b   MacLeod, Veronica ^b   Edmondson, Ricky D ^b   Speck, Samuel H ^c   Forrest, J Craig ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY AFFINITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA SYNTHESIS; EMBRYO; ENZYME ACTIVATION; GAMMAHERPESVIRINAE; GENE AMPLIFICATION; MASS SPECTROMETRY; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROGENY; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; VIRION; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ANIMALS; GAMMAHERPESVIRINAE; HUMANS; MAP KINASE KINASE 4; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; VIRAL PROTEINS; VIRUS REPLICATION;

MURINAE;

EID: 84870714294     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01432-12     Document Type: Article

References (56)

1. Adler H, Messerle M, Wagner M, Koszinowski UH. 2000. Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J. Virol. 74:6964-6974.
2. Autret A, et al. 2007. Poliovirus induces Bax-dependent cell death mediated by c-Jun NH2-terminal kinase. J. Virol. 81:7504 -7516.
3. Bennett BL, et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98:13681-13686.
4. Bortz E, et al. 2003. Identification of proteins associated with murine gammaherpesvirus 68 virions. J. Virol. 77:13425-13432.
5. Boyne JR, Jackson BR, Taylor A, Macnab SA, Whitehouse A. 2010.Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYMto enhance translation of viral intronless mRNAs.EMBOJ. 29:1851-1864.
6. Cheng BY, et al. 2012. Tiled microarray identification of novel viral transcript structures and distinct transcriptional profiles during two modes of productive murine gammaherpesvirus 68 infection. J. Virol.86:4340-4357.
7. Chu WM, et al. 1999. JNK2 and IKKβ are required for activating the innate response to viral infection. Immunity 11:721-731.
8. Clarke P, et al. 2004. JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells. J. Virol. 78:13132-13138.
9. Damania B. 2007. DNA tumor viruses and human cancer. Trends Microbiol.15:38-44.
10. Deng H, Liang Y, Sun R. 2007. Regulation of KSHV lytic gene expression.Curr. Top. Microbiol. Immunol. 312:157-183.
11. Dittmer DP, Richards KL, Damania B. 2012. Treatment of Kaposi sarcoma-associated herpesvirus-associated cancers. Front. Microbiol. 3:141.doi:10.3389/fmicb.2012.00141.
12. Fields BN, Knipe DM, Howley PM. 2007. Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
13. Forrest JC, Paden CR, Allen RD III, Collins J, Speck SH. 2007. ORF73-null murine gammaherpesvirus 68 reveals roles for mLANA and p53 in virus replication. J. Virol. 81:11957-11971.
14. Forrest JC, Speck SH. 2008. Establishment of B-cell lines latently infected with reactivation-competent murine gammaherpesvirus 68 provides evidence for viral alteration of a DNA damage-signaling cascade. J. Virol.82:7688-7699.
15. Gargano LM, Moser JM, Speck SH. 2008. Role for MyD88 signaling in murine gammaherpesvirus 68 latency. J. Virol. 82:3853-3863.
16. Gonzalez CM, et al. 2006. Identification and characterization of the Orf49 protein of Kaposi's sarcoma-associated herpesvirus. J. Virol. 80:3062-3070.
17. Grundhoff A, Ganem D. 2004. Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J. Clin. Invest. 113:124 -136.
18. Hagemeier SR, Barlow EA, Kleman AA, Kenney SC. 2011. The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner. J. Virol. 85:4318-4329.
19. Hamza MS, et al. 2004. ORF36 protein kinase of Kaposi's sarcoma her-pesvirus activates the c-Jun N-terminal kinase signaling pathway. J. Biol.Chem. 279:38325-38330.
20. Hornbeck PV, Chabra I, Kornhauser JM, Skrzypek E, Zhang B. 2004.PhosphoSite: a bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 4:1551-1561.
21. Hughes DJ, et al. 2010. Characterization of a novel wood mouse virus related to murid herpesvirus 4. J. Gen. Virol. 91:867-879.
22. Jackson BR, Noerenberg M, Whitehouse A. 2012. The Kaposi's sarcomaassociated herpesvirus ORF57 protein and its multiple roles in mRNA biogenesis. Front. Microbiol. 3:59. doi:10.3389/fmicb.2012.00059.
23. Johnson LS, Willert EK, Virgin HW. 2010. Redefining the genetics of murine gammaherpesvirus 68 via transcriptome-based annotation. Cell Host Microbe 7:516-526.
24. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
25. Laichalk LL, Thorley-Lawson DA. 2005. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J.Virol. 79:1296-1307.
26. Li X, et al. 2010. Tpl2/AP-1 enhances murine gammaherpesvirus 68 lytic replication. J. Virol. 84:1881-1890.
27. Liang X, Collins CM, Mendel JB, Iwakoshi NN, Speck SH. 2009.Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog.5:e1000677. doi:10.1371/journal.ppat.1000677.
28. Loh J, et al. 2011. Identification and sequencing of a novel rodent gammaherpesvirus that establishes acute and latent infection in laboratory mice. J. Virol. 85:2642-2656.
29. Lu X, et al. 2010. The PI3K/Akt pathway inhibits influenza A virusinduced Bax-mediated apoptosis by negatively regulating the JNK pathway via ASK1. J. Gen. Virol. 91:1439 -1449.
30. Martin D, Gutkind JS. 2008. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene 27(Suppl.2):S31-S42.
31. Martinez-Guzman D, et al. 2003. Transcription program of murine gammaherpesvirus 68. J. Virol. 77:10488-10503.
32. Moser JM, Farrell ML, Krug LT, Upton JW, Speck SH. 2006. A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge. J. Virol.80:1592-1598.
33. Nociari M, Ocheretina O, Murphy M, Falck-Pedersen E. 2009. Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling. J. Virol. 83:4081- 4091.
34. Noh CW, et al. 2012. The virion-associated open reading frame 49 of murine gammaherpesvirus 68 promotes viral replication both in vitro and in vivo as a derepressor of RTA. J. Virol. 86:1109 -1118.
35. Pan H, Xie J, Ye F, Gao SJ. 2006. Modulation of Kaposi's sarcomaassociated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen-activated protein kinase pathways during primary infection. J. Virol. 80:5371-5382.
36. Pavlova I, Lin CY, Speck SH. 2005. Murine gammaherpesvirus 68 Rtadependent activation of the gene 57 promoter. Virology 333:169-179.
37. Pavlova IV, HW Virgin IV, Speck SH. 2003. Disruption of gammaherpesvirus 68 gene 50 demonstrates that Rta is essential for virus replication.J. Virol. 77:5731-5739.
38. Pipas J, Damania B. 2009. DNA tumor viruses. Springer-Verlag, New York, NY.
39. Raman M, Chen W, Cobb MH. 2007. Differential regulation and properties of MAPKs. Oncogene 26:3100 -3112.
40. Rincon M, Davis RJ. 2009. Regulation of the immune response by stressactivated protein kinases. Immunol. Rev. 228:212-224.
41. Sharma-Walia N, et al. 2005. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J. Virol. 79:10308 -10329.
42. Song MJ, et al. 2005. Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis. Proc. Natl. Acad. Sci. U. S. A. 102:3805-3810.
43. Staudt MR, Dittmer DP. 2007. The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. Curr. Top. Microbiol. Immunol. 312:71-100.
44. Sun CC, Thorley-Lawson DA. 2007. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter. J. Virol. 81:13566 -13577.
45. Upton JW, Speck SH. 2006. Evidence for CDK-dependent and CDKindependent functions of the murine gammaherpesvirus 68 v-cyclin. J.Virol. 80:11946 -11959.
46. Upton JW, van Dyk LF, Speck SH. 2005. Characterization of murine gammaherpesvirus 68 v-cyclin interactions with cellular CDKs. Virology 341:271-283.
47. Van der Velden J, et al. 2012. Differential requirement for c-Jun N-terminal kinase 1 in lung inflammation and host defense. PLoS One 7:e34638.doi:10.1371/journal.pone.0034638.
48. Virgin HW, IV, et al. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-5904.
49. Vogt PK. 2001. Jun, the oncoprotein. Oncogene 20:2365-2377.
50. Wang SE, et al. 2004. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, andMTApromoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J. Virol. 78:4248-4267.
51. Weck KE, Barkon ML, Yoo LI, Speck SH, Virgin HI. 1996. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J. Virol. 70:6775- 6780.
52. Wu TT, Tong L, Rickabaugh T, Speck S, Sun R. 2001. Function of Rta is essential for lytic replication of murine gammaherpesvirus 68. J. Virol.75:9262-9273.
53. Xie J, Ajibade AO, Ye F, Kuhne K, Gao SJ. 2008. Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways. Virology 371:139-154.
54. Xie J, Pan H, Yoo S, Gao SJ. 2005. Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways. J. Virol. 79:15027-15037.
55. Yu F, et al. 2007. B cell terminal differentiation factor XBP-1 induces reactivation of Kaposi's sarcoma-associated herpesvirus. FEBS Lett. 581:3485-3488.
56. Zapata HJ, Nakatsugawa M, Moffat JF. 2007. Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway. J. Virol. 81:977-990.